Initiative on Crohn and Collitis - Verricht ICC onderzoek

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort
R.K. Weersma
Doelgroep:
Crohn

High Frequency of Early Colorectal Cancer in Inflammatory Bowel Disease
M.W.M.D. Lutgens
Doelgroep:


Substantial increase of progression rate of flat low-grade dysplasia in inflammatory bowel disease after review by an expert panel.

Doelgroep:


Colorectal cancer in inflammatory bowel disease; a comparison between large cohorts from referral centrers and general hospitals.

Doelgroep:


• Guidelines for treatment with infliximab for Crohn's disease
Hommes DW
Doelgroep:
Crohn

• Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort
Weersma RK
Doelgroep:
Crohn

Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.
Festen EA
Doelgroep:
Colitis Ulcerosa

Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.
Festen EA
Doelgroep:
Colitis ulcerosa

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis
Claessen MM
Doelgroep:


Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
Lutgens MW
Doelgroep:


Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease
De Vries HS
Doelgroep:


Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease
De Vries, HS
Doelgroep:


Genome-wide association identifies multiple ulcerative colitis susceptibility loci
McGovern DP
Doelgroep:
colitis ulcerosa

Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease
Fransen K
Doelgroep:


Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease
Van der Woude CJ
Doelgroep:
Crohn

Guideline 'Diagnosis and treatment of inflammatory bowel disease in adults'. II. Special situations and organisation of medical care
Dijkstra G.
Doelgroep:


Guideline 'Diagnosis and treatment of inflammatory bowel disease in adults'. I. Diagnosis and treatment
Van Bodegraven AA
Doelgroep:


Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
Melum E
Doelgroep:


Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis
Diaz-Gallo LM
Doelgroep:
Colitis Ulcerosa

A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease
Festen EA
Doelgroep:


Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands
Baars JE
Doelgroep:


HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort
Van Sommeren S
Doelgroep:


Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
Nijmeijer RM
Doelgroep:


Misclassification of dysplasia in patients with inflammatory bowel disease: Consequences for progression rates to advanced neoplasia
Van Schaik FD
Doelgroep:


Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study
Vos AC
Doelgroep:


Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease
Oostlander AE
Doelgroep:
Crohn

Belangstellenden kunnen de richtlijn opvragen via het secretariaat van het ICC (zie 'contact' boven aan deze pagina).

Verricht ICC onderzoek